ASMS 2017 – Analytical laboratories can now obtain high quality data with new triple quadrupole mass spectrometry technology designed to provide exceptional performance for the most demanding...

ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, and BIOCRATES Life Sciences AG, a global leader in metabolic phenotyping, today launched a ready-to-use kit for...

ASMS 2017 – Scientists facing highly complex characterization challenges can now gain a deeper understanding of their samples with new enhancements to the industry-leading Thermo Scientific...

ASMS 2017 – Life science researchers can gain greater insights from their metabolomic and proteomic data and be more productive by using new software and cloud-based solutions from Thermo Fisher...

ASMS 2017 – Scientists studying complex protein samples can now take advantage of a new high-performing Orbitrap mass spectrometer designed to quickly and consistently produce superior data...

Boehringer Ingelheim today announced that Phase II results from LUME-Meso, a randomized, double-blind, placebo-controlled trial, have been presented as part of an Oral Abstract Session at the 2017...

ASMS 2017 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, strengthened its leadership in mass spectrometry by launching new technologies to advance cutting-edge...

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced new Phase 1...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced smart chemotherapy DS-8201 demonstrated a favorable safety profile and promising antitumor activity in patients with...

Poseida Therapeutics, Inc. ("Poseida"), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced preclinical data demonstrating...

Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") today announced that it will provide an online audio simulcast of its presentation to the investment community at...

Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, today announced that the company and its research...

ProTrials Research, Inc., a leader in the clinical research organization (CRO) industry, announced today that they will be exhibiting at the upcoming Drug Information Association (DIA) annual...

How will teledentistry be implemented to reach those in need, empower careers in dental hygiene and build all types of dental practices? MouthWatch, the creators of the award-winning MouthWatch...

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of two molecular profiling studies that provide...

Clementia Pharmaceuticals, Inc. today announced that it will host a symposium entitled "Novel Perspectives in Two Rare Bone Disorders" on Monday, June 12th, 2017, at the 8th International...

Alliance Data Systems Corporation (NYSE: ADS), a leading global provider of data-driven marketing and loyalty solutions, today announced that Ed Heffernan, chief executive officer, will present at...

Salesforce (NYSE: CRM), the global leader in CRM, today announced that Salesforce executives will participate in the following investor events: Monday, June 5, 2017: John Wookey, EVP, Platform,...

EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that it will host the CSRA SHRM (Society for Human...

Janssen Research & Development, LLC (Janssen) today announced longer follow-up of up to four years from the pivotal Phase 3 RESONATE™ trial (PCYC-1112) of IMBRUVICA® (ibrutinib) vs. ofatumumab...

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), is a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical...

Long-term follow-up results from the pivotal Phase 3 RESONATE™ trial (PCYC-1112) showed continued survival rates in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small...

Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced a new family of wideband plastic...

Bruker is show-casing several new and innovative, high-performance mass spectrometry solutions for metabolomics, proteoform profiling and toxicology at ASMS 2017 (www.asms.org). Bruker is also...

IMBRUVICA (ibrutinib) reduced cells that may play an important role in the survival and proliferation of chronic lymphocytic leukemia (CLL), without negatively impacting non-cancerous immune...